Therefore, while further research is needed to fully elucidate the biological functions and therapeutic potential of the caveolar network, targeting Cav-1 and caveolae-associated pathways holds promise as a novel therapeutic strategy for gliomas and other brain tumors. This evidence concerns the gene CAV1 and central nervous system cancer.